个人中心 - 老虎社区

金融管理家

IP属地：未知

帖子 · 6帖子 · 6
关注 · 0关注 · 0
粉丝 · 0粉丝 · 0

- 金融管理家金融管理家
  ·2025-12-25
  $MIRXES-B(02629)$ 早筛赛道玩家不少，但大多卡在“有创”或者“低灵敏度”的坑里。觅瑞用miRNA技术破局，无创的抽血检测+灵敏度达到87%，远超行业平均，还解决了产业化难题，不用依赖复杂设备。这种“精准+便捷+性价比”的差异化优势，让它在东南亚快速普及，也为全球扩张铺路，赛道稀缺性拉满。
  332 评论
  1
  分享
  举报
- 金融管理家金融管理家
  ·2025-12-18
  $MIRXES-B(02629)$ 生物科技出海，专利是硬通货。觅瑞就是凭着miRNA专利技术在早筛赛道快速突围的。不光有自研的技术平台，还有旗舰胃癌早筛产品，在国内外都获得了监管机构批准，且早已在多个国家开始推广应用，是觅瑞开拓全球市场的关键支点。
  376 评论
  1
  分享
  举报
- 金融管理家金融管理家
  ·2025-12-04
  $MIRXES-B(02629)$ 现在全球顶尖的癌症早筛公司，都在抢着扩大市场份额。核心技术突破与权威认证是企业打开局面的入场券。觅瑞的觅小卫最近国内获批，而且之前已经有欧盟CE认证和美国FDA突破性医疗器械认证，技术硬、口碑好，未来发展潜力巨大。
  294 评论
  1
  分享
  举报
- 金融管理家金融管理家
  ·2025-11-06
  $MIRXES-B(02629)$ 现在企业出海不容易，尤其像欧美那些技术门槛高的地方。参考觅瑞这种医疗创新型的企业，除了自身实力够强，还要灵活应对各国不同的政策，才能在国际市场上吃得开。
  569 评论
  1
  分享
  举报
- 金融管理家金融管理家
  ·2025-07-16
  早筛企业出海正从发达国家向新兴市场双轨并行，针对不同市场特点制定差异化策略，在欧美靠技术认证，在东南亚就侧重成本优势和渠道。今年5月上市的觅瑞，他家的早筛产品就已经在欧美和亚太市场有比较成熟的商业化规模
  917 评论
  1
  分享
  举报
- 金融管理家金融管理家
  ·2025-07-07
  英伟达怎么样
  522 评论
  1
  分享
  举报

热议股票

{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"4214973229750030","uuid":"4214973229750030","gmtCreate":1751870042470,"gmtModify":1751875012825,"name":"金融管理家","pinyin":"jrgljjinrongguanlijia","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/1b1c7434a8ac5dda85bd333ea43ff47f","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":0,"headSize":5,"tweetSize":6,"questionSize":0,"limitLevel":999,"accountStatus":1,"level":{"id":0,"name":"","nameTw":"","represent":"","factor":"","iconColor":"","bgColor":""},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[],"userBadgeCount":0,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":514782695223808,"gmtCreate":1766655030008,"gmtModify":1766655031770,"author":{"id":"4214973229750030","authorId":"4214973229750030","name":"金融管理家","avatar":"https://static.tigerbbs.com/1b1c7434a8ac5dda85bd333ea43ff47f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4214973229750030","idStr":"4214973229750030"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/02629\">$MIRXES-B(02629)$</a> 早筛赛道玩家不少，但大多卡在“有创”或者“低灵敏度”的坑里。觅瑞用miRNA技术破局，无创的抽血检测+灵敏度达到87%，远超行业平均，还解决了产业化难题，不用依赖复杂设备。这种“精准+便捷+性价比”的差异化优势，让它在东南亚快速普及，也为全球扩张铺路，赛道稀缺性拉满。","listText":"<a href=\"https://laohu8.com/S/02629\">$MIRXES-B(02629)$</a> 早筛赛道玩家不少，但大多卡在“有创”或者“低灵敏度”的坑里。觅瑞用miRNA技术破局，无创的抽血检测+灵敏度达到87%，远超行业平均，还解决了产业化难题，不用依赖复杂设备。这种“精准+便捷+性价比”的差异化优势，让它在东南亚快速普及，也为全球扩张铺路，赛道稀缺性拉满。","text":"$MIRXES-B(02629)$ 早筛赛道玩家不少，但大多卡在“有创”或者“低灵敏度”的坑里。觅瑞用miRNA技术破局，无创的抽血检测+灵敏度达到87%，远超行业平均，还解决了产业化难题，不用依赖复杂设备。这种“精准+便捷+性价比”的差异化优势，让它在东南亚快速普及，也为全球扩张铺路，赛道稀缺性拉满。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/514782695223808","isVote":1,"tweetType":1,"viewCount":332,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":512017874785160,"gmtCreate":1766031402355,"gmtModify":1766034772812,"author":{"id":"4214973229750030","authorId":"4214973229750030","name":"金融管理家","avatar":"https://static.tigerbbs.com/1b1c7434a8ac5dda85bd333ea43ff47f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4214973229750030","idStr":"4214973229750030"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/02629\">$MIRXES-B(02629)$</a> 生物科技出海，专利是硬通货。觅瑞就是凭着miRNA专利技术在早筛赛道快速突围的。不光有自研的技术平台，还有旗舰胃癌早筛产品，在国内外都获得了监管机构批准，且早已在多个国家开始推广应用，是觅瑞开拓全球市场的关键支点。","listText":"<a href=\"https://laohu8.com/S/02629\">$MIRXES-B(02629)$</a> 生物科技出海，专利是硬通货。觅瑞就是凭着miRNA专利技术在早筛赛道快速突围的。不光有自研的技术平台，还有旗舰胃癌早筛产品，在国内外都获得了监管机构批准，且早已在多个国家开始推广应用，是觅瑞开拓全球市场的关键支点。","text":"$MIRXES-B(02629)$ 生物科技出海，专利是硬通货。觅瑞就是凭着miRNA专利技术在早筛赛道快速突围的。不光有自研的技术平台，还有旗舰胃癌早筛产品，在国内外都获得了监管机构批准，且早已在多个国家开始推广应用，是觅瑞开拓全球市场的关键支点。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/512017874785160","isVote":1,"tweetType":1,"viewCount":376,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":507078993813904,"gmtCreate":1764829181553,"gmtModify":1764829889105,"author":{"id":"4214973229750030","authorId":"4214973229750030","name":"金融管理家","avatar":"https://static.tigerbbs.com/1b1c7434a8ac5dda85bd333ea43ff47f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4214973229750030","idStr":"4214973229750030"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/02629\">$MIRXES-B(02629)$</a> 现在全球顶尖的癌症早筛公司，都在抢着扩大市场份额。核心技术突破与权威认证是企业打开局面的入场券。觅瑞的觅小卫最近国内获批，而且之前已经有欧盟CE认证和美国FDA突破性医疗器械认证，技术硬、口碑好，未来发展潜力巨大。","listText":"<a href=\"https://laohu8.com/S/02629\">$MIRXES-B(02629)$</a> 现在全球顶尖的癌症早筛公司，都在抢着扩大市场份额。核心技术突破与权威认证是企业打开局面的入场券。觅瑞的觅小卫最近国内获批，而且之前已经有欧盟CE认证和美国FDA突破性医疗器械认证，技术硬、口碑好，未来发展潜力巨大。","text":"$MIRXES-B(02629)$ 现在全球顶尖的癌症早筛公司，都在抢着扩大市场份额。核心技术突破与权威认证是企业打开局面的入场券。觅瑞的觅小卫最近国内获批，而且之前已经有欧盟CE认证和美国FDA突破性医疗器械认证，技术硬、口碑好，未来发展潜力巨大。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/507078993813904","isVote":1,"tweetType":1,"viewCount":294,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":497174305219424,"gmtCreate":1762403287688,"gmtModify":1762405039188,"author":{"id":"4214973229750030","authorId":"4214973229750030","name":"金融管理家","avatar":"https://static.tigerbbs.com/1b1c7434a8ac5dda85bd333ea43ff47f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4214973229750030","idStr":"4214973229750030"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/02629\">$MIRXES-B(02629)$</a> 现在企业出海不容易，尤其像欧美那些技术门槛高的地方。参考觅瑞这种医疗创新型的企业，除了自身实力够强，还要灵活应对各国不同的政策，才能在国际市场上吃得开。","listText":"<a href=\"https://laohu8.com/S/02629\">$MIRXES-B(02629)$</a> 现在企业出海不容易，尤其像欧美那些技术门槛高的地方。参考觅瑞这种医疗创新型的企业，除了自身实力够强，还要灵活应对各国不同的政策，才能在国际市场上吃得开。","text":"$MIRXES-B(02629)$ 现在企业出海不容易，尤其像欧美那些技术门槛高的地方。参考觅瑞这种医疗创新型的企业，除了自身实力够强，还要灵活应对各国不同的政策，才能在国际市场上吃得开。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/497174305219424","isVote":1,"tweetType":1,"viewCount":569,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":457095333789696,"gmtCreate":1752632486220,"gmtModify":1752632504465,"author":{"id":"4214973229750030","authorId":"4214973229750030","name":"金融管理家","avatar":"https://static.tigerbbs.com/1b1c7434a8ac5dda85bd333ea43ff47f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4214973229750030","idStr":"4214973229750030"},"themes":[],"htmlText":"早筛企业出海正从发达国家向新兴市场双轨并行，针对不同市场特点制定差异化策略，在欧美靠技术认证，在东南亚就侧重成本优势和渠道。今年5月上市的觅瑞，他家的早筛产品就已经在欧美和亚太市场有比较成熟的商业化规模","listText":"早筛企业出海正从发达国家向新兴市场双轨并行，针对不同市场特点制定差异化策略，在欧美靠技术认证，在东南亚就侧重成本优势和渠道。今年5月上市的觅瑞，他家的早筛产品就已经在欧美和亚太市场有比较成熟的商业化规模","text":"早筛企业出海正从发达国家向新兴市场双轨并行，针对不同市场特点制定差异化策略，在欧美靠技术认证，在东南亚就侧重成本优势和渠道。今年5月上市的觅瑞，他家的早筛产品就已经在欧美和亚太市场有比较成熟的商业化规模","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/457095333789696","isVote":1,"tweetType":1,"viewCount":917,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":454034530258960,"gmtCreate":1751870257483,"gmtModify":1751873133139,"author":{"id":"4214973229750030","authorId":"4214973229750030","name":"金融管理家","avatar":"https://static.tigerbbs.com/1b1c7434a8ac5dda85bd333ea43ff47f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4214973229750030","idStr":"4214973229750030"},"themes":[],"htmlText":"英伟达怎么样","listText":"英伟达怎么样","text":"英伟达怎么样","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/454034530258960","isVote":1,"tweetType":1,"viewCount":522,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"defaultTab":"posts","isTTM":false}